Rani Therapeutics Holdings, Inc.
RANI
$0.84
-$0.03-3.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.39M | -7.03M | -10.31M | -5.41M | -6.69M |
| Total Depreciation and Amortization | 152.00K | 161.00K | 186.00K | 223.00K | 240.00K |
| Total Amortization of Deferred Charges | -- | -- | 33.00K | 58.00K | 58.00K |
| Total Other Non-Cash Items | 1.60M | 1.34M | 4.41M | 328.00K | -618.00K |
| Change in Net Operating Assets | -3.39M | -960.00K | 5.97M | -260.00K | 1.22M |
| Cash from Operations | -9.03M | -6.50M | 294.00K | -5.06M | -5.80M |
| Capital Expenditure | -32.00K | -15.00K | 0.00 | 0.00 | -37.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.52M | -2.44M | -30.97M | 0.00 | 5.75M |
| Cash from Investing | -14.56M | -2.45M | -30.97M | 0.00 | 5.71M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -9.47M | -3.75M | -3.75M |
| Issuance of Common Stock | 18.82M | 5.00K | 112.97M | 2.94M | 3.95M |
| Repurchase of Common Stock | -9.00K | -32.00K | -21.00K | -7.00K | -8.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -4.28M | -189.00K | -- |
| Cash from Financing | 18.81M | -27.00K | 44.85M | -1.01M | 188.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.78M | -8.97M | 14.17M | -6.07M | 105.00K |